Skip to main content

Statement regarding PIP implants warning from the MHRA

London - 31 March 2010 - As the discovery that the substance inside a cut-price breast implant is not what had been tested initially to make its use legal, the British Association of Aesthetic Plastic Surgeons (, the not-for-profit organisation established for the advancement of education and practice of Aesthetic Plastic Surgery for public benefit, warns the public that choosing a provider solely on price can backfire.

As the French company behind PIP implants goes into liquidation, consultant plastic surgeon and BAAPS former President Douglas McGeorge says; "There have been questions about the safety and efficacy of these implants in the past – but as they were a ‘cheap’ option they may have proven popular with the commercial chains. Although it is unlikely that anyone’s health is in immediate danger, this must remind everyone that price should never be the sole consideration when choosing a cosmetic surgery provider."

According to Nigel Mercer, consultant plastic surgeon and BAAPS President; "Concerned patients should contact their surgeon to find out what implants they have. Only PIP implants are involved and as yet there is no evidence that the gel they contained is harmful and we understand that it will not leak into the body. "

The Medicines and Healthcare products Regulatory Agency (MHRA) is in close discussions with the French Regulatory Authority for Devices (AFSSAPS) as the product has now been taken off the market, and will be indicating if follow-up of patients is required.


The BAAPS (, based at the Royal College of Surgeons, is a not-for-profit organisation, established for the advancement of education and practice of Aesthetic Plastic Surgery for public benefit. Members undergo thorough background screening before they can join. Information about specific procedures and surgeons’ contact details can be found on the website, or by contacting their office at 020 7430 1840. Further materials can be posted to members of the public seeking specialised information. BAAPS is also on Twitter:   and Facebook:

For all media enquiries, please contact


View other press releases